PAM
GRTX

Panagora Asset Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Panagora Asset Management’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-566
Closed -$6K – 2465
2021
Q2 		$6K Sell
566
-35,578
-98% -$289K ﹤0.01% 2454
2021
Q1 		$319K Buy
36,144
+2,413
+7% +$26.5K ﹤0.01% 1538
2020
Q4 		$345K Buy
33,731
+33,042
+4,796% +$361K ﹤0.01% 1369
2020
Q3 		$6K Buy
+689
New +$5.46K ﹤0.01% 2421

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Panagora Asset Management's GRTX Position: Q3 2021 in Review

Panagora Asset Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2021, closing a stake of 566 shares — an estimated $6K sold.

Panagora Asset Management first reported a position in GRTX in Q3 2020 and held it in 4 quarters. The position peaked at $345K in Q4 2020. 40 funds tracked by Wall St. Rank hold GRTX as of Q3 2021.

  • Panagora Asset Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 566 Galera Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $6K.
  • Panagora Asset Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Panagora Asset Management's Galera Therapeutics, Inc. Common Stock position peaked at $345K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.